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Abstract
Background: Obesity and its comorbidities such as insulin resis-
tance, endothelial dysfunction, hypertension, type 2 diabetes and 
atherosclerosis have been associated with chronic inflammation and 
oxidative stress. Weight loss with maintenance is not always possible. 
Bariatric surgery has been proved to be the only efficient method for 
weight reduction in patients with clinically severe obesity. It leads to 
significant weight loss and improvement and/or remission of comorbi-
dities. On the other hand, considering that surgical intervention per se 
induces oxidative stress and inflammatory response, the objective of 
the present study was to verify if some inflammatory marker, TBARS 
and/or Vitamin E could be evaluated before gastric surgery and the 
relationship with clinical characteristics of the obesity.
Methods: A quantitative cross-sectional study was carried out at 
Clinica Ana Rosa (Santo André, SP, Brazil). 100 obese patients (BMI ≥ 
35-40 kg/m2) awaiting bariatric surgery were selected for this study. 
The control group included 29 individuals, BMI < 35 kg/m2, with or 
without associated comorbidities. The patients completed a struc-
tured interview. Weight, height, waist and hip circumferences were 
also collected. Blood was collected. Glucose (G), total cholesterol (TC), 
HDL cholesterol (HDLc), LDL cholesterol (LDLc), VLDL cholesterol (VL-
DLc), triglycerides (TG), high-sensitivity C-reactive protein (hs-CRP), vi-
tamin E (VIT E), fibrinogen (FIB), IL-6 (human interleukin-6), TNF-alpha 
and thiobarbituric acid reactive substances (TBARS) were measured.
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Introduction
Obesity and its comorbidities such as insulin resis-
tance, endothelial dysfunction, hypertension, type 2 
diabetes and atherosclerosis have been associated 
with chronic inflammation and oxidative stress [1].
Obesity is characterized by an inflammatory sta-
te reflected by chronic increases of inflammatory 
markers, including pro-inflammatory cytokines (e.g., 
IL-6, TNF-α) and C-reactive protein (CRP). Higher ex-
pression of inflammatory markers has been repor-
ted in the adipose tissue of obese patient compared 
with lean subjects, and this expression was reduced 
after weight loss [2].
The presence of oxidant stress can be measu-
red by using indirect indicators of lipid peroxidation 
such as TBARS (thiobarbituric acid-reactive substan-
ces), which is a good indicator of cell damage [3].
Obesity has been associated with low levels of 
antioxidant vitamins such as vitamin E but the rea-
sons are not clear. Vitamin E is one of the most im-
portant elements of the non-enzymatic antioxidant 
defense in biologic system [4]. 
Weight loss with maintenance is not always possi-
ble. Bariatric surgery has been proved to be the only 
efficient method for weight reduction in patients 
with clinically severe obesity [body mass index (BMI) 
≥ 40 kg/m2]. It leads to significant weight loss and 
improvement and/or remission of comorbidities (1).
On the other hand, considering that surgical in-
tervention per se induces oxidative stress (5) and 
inflammatory response (2), the objective of the 
present study was to verify if some inflammatory 
marker, TBARS and/or Vitamin E could be evaluated 
before gastric surgery and if them were different 
between obesity classes.
Patients and methods
A quantitative cross-sectional study was carried out 
at Clinica Ana Rosa (Santo André, SP, Brazil). The 
study protocol was approved by the Committee for 
Ethics in Research in humans of the Faculdade de 
Medicina do ABC, and it was in line with the World 
Medical Association Declaration of Helsinki.
The patients completed a structured interview 
to obtain the following data: gender, age, medical 
history, drug consumption and diseases. Weight, 
height, waist and hip circumferences were also co-
llected. Body mass index (BMI) was calculated accor-
ding to the formula: actual body weight (kg)/height 
(m2). The cutoff points used were those recommen-
ded by the WHO for classifying normal weight and 
excess weight, with the study participants qualifying 
as class II obesity, with BMI ≥ 35 kg/m2 < 40 kg/m2 
or class III obesity, with BMI ≥ 40 kg/m2. Bioelectri-
cal Impedance Analysis (BIA) and skinfold measure-
ments were also performed in order to obtain the 
muscle mass (MM).
100 obese patients (BMI ≥ 35-40 kg/m2) awai-
ting bariatric surgery were selected for this study. 
Results: Patients have shown increased serum levels of hs-CRP and 
FIB. In this study, class II and III obese patients awaiting bariatric sur-
gery and the control group had lower than normal VIT E levels and 
no significant changes in TBARS levels were observed. Conclusions: 
Of all markers evaluated hs-PCR and fibrinogen were found altered 
in obesity group patients. Therefore, our results reinforce the impor-
tance of evaluating inflammatory markers in obese patients before 
bariatric surgery.
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The control group included 29 individuals, BMI < 
35 kg/m2, with or without associated comorbi-
dities. Inclusion criteria were: 20 to 59 years-old 
adult patients, with no gender restrictions. Patients 
excluded from the study were younger than 20 or 
older than 60 years-old, with positive serological 
testing for hepatitis B or C or the human immu-
nodeficiency virus, and/or patients suffering from 
endogenous obesity. 
Blood samples were collected after a 12-h fast. 
The plasma and serum samples were separated by 
centrifugation and immediately aliquoted and sto-
red at -80ºC until analysis.
Biochemical parameters were measured in dupli-
cate. Glucose (G), total cholesterol (TC), HDL choles-
terol (HDLc), LDL cholesterol (LDLc), VLDL choleste-
rol (VLDLc) and triglycerides (TG) were determined 
by standard enzymatic methods. High-sensitivity C-
reactive protein (hs-CRP) levels were measured by 
ELISA kit. Serum vitamin E (VIT E) concentration was 
determined by high-performance liquid chromato-
graphy (HPLC) with UV detection and cholesterol 
concentration, using a Roche analyser and reagents. 
Fibrinogen (FIB) levels in plasma were measured by 
the Clauss method. IL-6 (human interleukin-6) levels 
were measured with Thermo Scientific Human IL-6 
ELISA Kits. TNF-alpha assay kits were used to mea-
sure levels of tumor necrosis factor alpha (TNF-α). 
For quantitative determination of thiobarbituric 
acid reactive substances (TBARS) was used Quan-
tiChrom™ TBARS Assay Kit.
The statistical analysis was carried out using Sig-
maStat 3.1 Software (Sigma Stat Software Inc., Ri-
chmond, CA, USA). The rejection level for a null 
hypothesis was 0.05. Normality was evaluated by 
the Kolmogorov-Smirnov test. Differences between 
groups were tested using the t-test or the Mann-
Whitney test. Correlations between levels of TBARS, 
VIT E, FIB, IL-6, TNF-α and hs-CRP were tested using 
the Spearman correlation test.
Two models of multiple linear regressions with 
stepwise backward elimination were used to veri-
fy the correlation between MM and BMI (as de-
pendent variables) and all other studied variables 
(known as independent variables). Independent 
variables were the following ones: age, gender, 
TBARS, TC, HDLc, LDLc, VLDLc, TG, G, FIB, IL-6, 
TNF-α, VIT E, and hs-CRP. Variables with deviation 
from the normal distribution were submitted to 
logarithmic transformations before the logistic re-
gression analysis.
Results
Table 1 shows clinical and laboratory parameters 
from the obese patients (BMI ≥ 35-40 kg/m2) awai-
ting bariatric surgery and the control group. Diffe-
rences between age (38.70 versus 44.32) and LDLc 
Table 1.  Gender, age, BMI, TBARS, TC, HDLc, LDLc, VLDLc, TG and G in class II and III obese patients 
before undergoing bariatric surgery and control group.
Group N Gender
Age 
(years)
BMI 
(kg/m2)
TBARS 
(mg/dL)
TC 
(mg/dL)
HDLc 
(mg/dL)
LDLc 
(mg/dL)
VLDLc 
(mg/dL)
TG 
(mg/dL)
G 
(mg/dL)
Class II 
and III 
obese 
patients
100
86 W 14 
M
38.70* 
(13.29)
41.38 
(4.68)
3.42 
(1.46)
196.62 
(39.78)
44.14 
(12.50)
122.88* 
(36.28)
23.88 
(11.03)
129.22 
(67.30)
104.13 
(52.96)
Control 29
22 W 7 
M
44.32* 
(10.90)
32.42 
(1.39)
3.49 
(1.32)
208.04 
(41.20)
46.51 
(12.87)
142.25* 
(37.79)
23.66 
(15.31)
119.41 
(74.16)
96.85 
(21.15)
Results as mean and SD. W: women. M: men. BMI: body mass index. TBARS: thiobarbituric acid-reactive substances. TC: 
total cholesterol. HDLc: HDL cholesterol. LDLc: LDL cholesterol. VLDLc: VLDL cholesterol. TG: triglycerides. G: glucose. * P < 
0.05 (t-test).
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(122.88 versus 142.25) were evident between the 
groups. 
Using Mann-Whitney test, it was possible to de-
tect that hs-CRP (11.31 versus 7.89) was significant 
and statistically different between groups (Table 2). 
Moreover, it was possible to verify a direct correla-
tion between VIT E (17.36) and hs-CRP (11.31) (P = 
0.047) in class II and III obese patients and between 
VIT E (19.11) and FIB (117.04) (P = 0.001) in control 
group.
The multiple linear regression analysis with ste-
pwise backward elimination was used to determi-
ne the correlation between muscular mass and the 
independent variables (BMI, TBARS, HDLc, LDLc, 
VLDLc, TG, G, FIB, IL-6, TNF-α, VIT E and hs-CRP) 
(Table 3). Statistic program eliminated those inde-
pendent variables that have not shown significant 
correlation. Data have shown that higher values of 
MM were associated to greater TNF-α levels. On 
the other hand, lower values of MM showed signi-
ficantly greater VIT E and IL-6 levels.
Table 4 shows the relationship between BMI in-
dependent variables that have shown significant 
correlation. BMI was associated to a negative co-
rrelation with age and a positive correlation with 
glucose. This model explains 33.7% of the BMI va-
riation between the individuals with a test power of 
88.8% considering an alpha level of 0.05.
Table 3.  Multiple linear regression analysis to test the relation between muscular mass and independent 
variables.
Dependent variable Independent variables Coefficient P-value
Meaning of the Model
R2 P-value
Test power 
(α = 0.05)
ln (MM %)
Constant 3.759 -
0.591 < 0.001 1.000
Gender -0.156 < 0.001
Age 0.003 0.016
ln (VLDLc) 0.089 0.013
ln (IL-6) -0.095 0.027
ln (TNF-α) 0.073 0.037
VIT E -0.007 0.029
MM: muscular mass. VLDLc: VLDL cholesterol. IL-6: Interleukin 6. TNF-α: tumor necrosis factor alpha. VIT E: vitamin E. ln: 
logarithmic transformation. Normality test: P = 0.653. Constant variance assumption: P = 0.250
Table 2.  VIT E, IL-6, TNF-α, hs-CRP and FIB in class II and III obese patients before undergoing bariatric 
surgery and control group.
Group N VIT E (mg/dL) IL-6 (mg/dL) TNF-α (mg/dL) hs-CRP (mg/dL) FIB (mg/dL)
Class II and III 
obese patients
100
17.36  
(5.89)
2.51 
(1.49)
10.89 
(4.86)
11.31* † 
(7.99)
109.73 
(50.51)
Control 29
19.11 
(6.85)
2.74 
(2.78)
8.96 
(3.36)
7.89* 
(9.13)
117.04 ‡ 
(44.30)
Results as mean and SD. VIT E: vitamin E. IL-6: Interleukin 6. TNF-α: tumor necrosis factor alpha. Hs-CRP: high-sensitivity 
C reactive protein. FIB: fibrinogen. † P = 0.047; r = 0.213 (Spearman's correlation). ‡ P = 0.001; r = 0.613 (Spearman's 
correlation). * P < 0.05 (Mann-Whitney test).
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Discussion
In this study, class II and III obese patients awaiting 
bariatric surgery and the control group had lower 
than normal reference of VIT E levels. Many authors 
have shown that obesity contributes to the develo-
pment of chronic diseases and systemic oxidative 
stress, mainly because of the reduction in antioxi-
dant defenses [5, 6]. Interestingly, in this study were 
not observed differences because all patients eva-
luated were obese (Control group and Class II and 
III obese patients). 
The two studied groups showed increased hs-
CRP levels. It has now been firmly established that 
adipose tissue is associated with increased inflam-
matory markers, proinflammatory adipokines, such 
as high-sensitivity C-reactive protein (hs-CRP), IL-6 
and TNF-α [7-10]. It is already known that the evi-
dent rise of the inflammatory status in obesity may 
be associated to the development of other disorders, 
such as insulin resistance (IR) and metabolic syn-
drome (MS) [11]. Furthermore, of the inflammatory 
markers studied the hs-PCR seems to be elected to 
show differences between the obesity classes. 
Some authors have shown that the expression 
of TNF-α mRNA in the adipose tissue is positively 
correlated to the body fat, insulin and TG levels [12]. 
High TNF-α levels in obese patients may reduce the 
insulin sensibility by influencing the phosphorylation 
status at the insulin receptor [13]. In this present 
study no significant change has been observed at 
TNF-α level.
At the adipose tissue, IL-6 and its receptor are 
expressed by both adipocytes and matrix of the 
adipose tissue. IL-6 expression at the adipose tis-
sue and its plasma concentrations are positively 
related to obesity, to glucose intolerance, to insulin 
resistance and to hs-CRP production associated to 
cardiovascular complications [14]. Despite the rela-
tion between hs-CRP and IL-6 has been observed 
in the literature, no correlation between them was 
observed in the studied groups. 
Cabrera et al. [15] have shown that before the 
surgery obese patients usually present higher levels 
of inflammatory markers and lower levels of antio-
xidant substances compared to control group. One 
year after Roux-en-Y bypass gastroplasty the anti-
oxidant protection improved and the inflammatory 
markers had decreased. 
Class II and III obese patients awaiting bariatric 
surgery and the control group have shown increa-
sed serum FIB levels. Fibrinogen promotes clot for-
mation by increasing the fibrin formation, the pla-
telet aggregation and the plasma viscosity. It also 
promotes atherosclerosis by the proliferation of en-
dothelial cells in the smooth vascular muscular layer. 
High FIB levels increase the prevalence and the inci-
dence of cardiovascular diseases and are correlated 
to obesity [16]. 
Table 4.  Multiple linear regression analysis to test the relation between body mass index and independent 
variables.
Dependent variable Independent variables Coefficient P-value
Meaning of the Model
R2 P-value
Test power 
(α = 0.05)
BMI
Constant 2.97 -
0.337 0.007 0.888Age -0.003 0.010
ln (G) 0.183 0.006
BMI: body mass index. G: glucose. ln: logarithmic transformation. Normality test: P = 0.654. Constant variance assumption: 
P = 0.620.
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The excessive nutrient intake by obese patients 
seems to contribute to overproduction of reactive 
oxygen species (ROS). In this study, we did not ob-
serve TBARS changes between the groups. Howe-
ver, bariatric surgery seems to promote a protective 
effect in the protein oxidative damage and to im-
prove inflammation and obesity biomarkers. A pro-
bable mechanism involved in the reduction of the 
oxidative stress is the decrease of fat mass, blood 
lipids, and the partial normalization of endogenous 
antioxidant defense. As food intake after bariatric 
surgery is limited, lower amount of ROS is gene-
rated at the mitochondria and, consequently, less 
oxidative damage is produced [17].
Excess weight and accumulated fat in subjects 
with severe obesity seem to be related to increased 
inflammatory response. We suggest the inclusion 
of some biomarkers to verify inflammation in obe-
se patients. It is important investigating VIT E, hs-
CRP, and FIB serum levels in patients candidates to 
bariatric surgery. Our results suggest differences in 
hs-PCR and fibrinogen levels between obesity clas-
ses and them can be predictive to bariatric surgery. 
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